Umbilical Cord Mesenchymal Cellule souche for Liver Cirrhosis Patient Caused by Hepatitis B
Description détaillée:The study is investigating the effect and safety of stem cells therapy in patients with liver cirrhosis that is specifically caused by Hepatitis B infection, the participants will be chosen based on inclusive and exclusive criteria to ensure the eligibility of the patients for this study. The patients will be given therapy in the form of allogeneic mesenchymal stem cells transplantation, the stem cells in this study were provided from Prodia Stem Cell Indonesia (ProSTEM). The stem cells being will also be subjected to certain criteria to ensure safety. The data of this study will be derived from the observation results of the patients’ liver damage status in weeks 4, 6 et 12. Aside from that, hemodynamic will be conducted as a part of the observation
